References
- MacKenzie EL, Iwasaki K, Tsuji Y. Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid Redox Signal 2008;10(6):997-1030.
- Pulliam JF, Jennings CD, Kryscio RJ, Davis DG, Wilson D, Montine TJ, Schmitt FA, Markesbery WR. Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer’s disease and correlation with APOE, Am J Med Genet B Neuropsychiatr. Genet 2003;15:119B(1):48-53.
- Pietrangelo Hereditary hemochromatosis pathogenesis, diagnosis, and treatment. Gastroenterology 2010 Aug;139(2): 393-408.
- Mikhailova SV, Babenko VN, Ivanoshchuk DE, Gubina MA, Maksimov VN, Solovjova IG, Voevoda MI. Haplotype analysis of the HFE gene among populations of Northern Eurasia, in patients with metabolic disorders or stomach cancer, and in long-lived people. BMC Genet 2016;17:17(1):83.
- Ye K, Cao C, Lin X, O’Brien KO, Gu Z. Natural selection on HFE in Asian populations contributes to enhanced non-heme iron absorption. BMC Genetics 2015 Jun 10;16:61.
- Sikorska K, Romanowski T, Stalke P, Iżycka-Świeszewska E, Bielawski KP. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int. 2011;10(3):270-275.
- Gómez-Llorente C, Miranda-León MT, Blanco S, Gandia-Pla S, Gómez-Capilla JA, Fárez-Vidal ME. Frequency and clinical expression of HFE gene mutations in a Spanish population of subjects with abnormal iron metabolism. Ann Hematol. 2005;84(10):650-655.
- Guo S, Frazer DM, Anderson GJ. Iron homeostasis: transport, metabolism, and regulation. Curr Opin Clin Nutr Metab Care 2016;19(4):276-281.
- Drakesmith H, Nemeth E, Ganz T. Ironing out Ferroportin. Cell Metab. 2015;3,22(5):777-787.
- Frazer DM, Anderson GJ. The regulation of iron transport. Biophactors 201;40(2):206-214.
- Kühn LC. Iron regulatory proteins and their role in controlling iron metabolism Metallomics 2015;7(2):232-243.
- Sangkhae V, Nemeth E. Regulation of the Iron Homeostatic hormone Hepcidin. Adv Nutr. 2017 Jan 17;8(1):126-136.
- Recalcati S, Gammella E, Cairo G. New perspectives on the molecular basis of the interaction between oxygen homeostasis and iron metabolism. Hypoxia (Auckl) 2015 Dec 11;3:93-103.
- Rishi G, Wallace DF, Subramaniam VN. Hepcidin: regulation of the master iron regulator. Biosci Rep. 2015 Mar 31;35(3):1-12.
- Hentze MW, Muckenthaler MU,Galy B, Camaschella C Two to tango: regulation of mammalian iron metabolism. Cell 2010;142(1):24-38.
- Ganz T. Systemic iron homeostasis. Physiol Rev. 2013;93(4):1721-1741.
- Corradini E, Rozier M, Meynard D, Odhiambo A, Lin HY, Feng Q, Migas MC, Britton RS, Babitt JL, Fleming RE. Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice without transferrin receptor 2 or Hfe. Gastroenterology 2011;141 (5):1907-1914.
- Corradini E, Garuti C, Montosi G, Ventura P, Andriopoulos B Jr, Lin HY, Pietrangelo A, Babitt JL. Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis. Gastroenterology. 2009;137(4):1489-1497.
- Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276(11):7806-7810.
- Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood 200610893204-3209
- Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 2007;109(1):353-358.
- Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet 2014;46(7):678-684.
- Bennett MJ, Lebrón JA, Bjorkman PJ. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Nature 2000 2000 Jan 6;403(6765):46-53.
- Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, Prass CE, Starnes SM, Wolff RK, Parkkila S, Sly WS, Schatzman RC. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem. 1997 May 30;272(22):14025-14028.
- Lebrón JA, Bjorkman PJ. The transferrin receptor binding site on HFE, the class I MHC-related protein mutated in hereditary hemochromatosis. J Mol Biol. 1999; Jun 18;289(4):1109-1118.
- Reuben A, Phénix M, Santos MM, Lapointe. The WT hemochromatosis protein HFE inhibits CD8+ T-lymphocyte activation. Eur J Immunol. 2014;44(6):1604-1614.
- Boucherma R, Kridane-Miledi H, Vives FL, Vauchy C, Borg C, Kleinclauss F, Fiette L, Tiberghien P, Lemonnier FA, Rohrlich PS, Huetz F. Loss of central and peripheral CD8+ T-cell tolerance to HFE in mouse models of human familial hemochromatosis. Eur J Immunol. 2012;42(4):851-862.
- Sikorska K, Bielawski KP, Romanowski T, Stalke P. Hemochromatoza dziedziczna- najczęstsza choroba genetyczna człowieka. Post Hig Med Dośw. 2006;60:667-676.
- Jahanshad N, Kohannim O, Hibar DP, Stein JL, McMahon KL, de Zubicaray GI, Medland SE, Montgomery GW, Whitfield JB, Martin NG, Wright MJ, Toga AW, Thompson PM. Brain structure in healthy adults is related to serum transferrin and the H63D polymorphism in the HFE gene. Proc Natl Acad Sci USA 2012; 3:109(14):E 851-859.
- Nandar W, Connor JR. HFE gene variants affect iron in the brain. J Nutr 2011 Apr 1;141(4):729S-739S.
- Jurgens CK, Jasinschi R, Ekin A, Witjes-Ané MN, Middelkoop H, van der Grond J, Roos RA. MRI T2 hypointensities in basal ganglia of premanifest Huntington disease. PLoS Curr 2010; 8: 2. pii: RRN1173
- Liu Y, Lee SY, Neely E, Nandar W, Moyo M, Simmons Z, Connor JR. Mutant H63D protein is associated with prolonged endoplasmatic reticulum stress and increased neuronal vulnerability. J Biol Chem. 2011; Apr 15;286(15):13161-13170.
- Liu B, Moloney A, Meehan S, Morris K, Thomas SE, Serpell LC, Hider R, Marciniak SJ, Lomas DA, Crowther DC. Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J Biol Chem. 2011;286(6):4248-4256
- Hall EC II, Lee SY, Simmons Z, Neely EB, Nandar W, Connor JR. Propyl-peptidyl isomerase, Pin 1, phpsphprylation is compromised in association with the expression of the HFE polymorphic allele, H63D. Bioch Bioph Acta 2010;1802(4):389-395.
- Bernaroch EE. Brain iron homeostasis and neurodegenerative disease. Neurology 2009;72(16):1436-1440.
- Selim MH, Ratan RR. The role of iron neurotoxicity in ishemic stroke. Ageing Res Rev. 2004; 3(3):345-353.
- Kaczorowska-Hac B, Myśliwiec M, Adamkiewicz-Drozynska E, Miłosz E. Hemochromatoza dziedziczna u dzieci. Dev Period ed. 2014;XVIII,2:266-271.
- Kaczorowska-Hac B, Maciejka-Kapuscinska L, Milosz-Bartoszewicz E, Adamkiewicz-Drozynska E. Hemochromatosis HFE in children-still underestimated. Ped Pol. 2012;87:358-362.
- Kaczorowska-Hac B, Luszczyk M Antosiewicz J, Ziolkowski W, Adamkiewicz-Drozynska E, Mysliwiec M, Milosz E, Kaczor JJ The impact of H63D HFE gene carriage on hemoglobin and iron status in children. Ann of Hem. 2016; 95(12):2043-2048.
- Kaczorowska-Hac B, Myśliwiec M, Tomaszewski M, Adamkiewicz-Drożyńska E, Miłosz E. Elevated hemoglobin concentration in 3 children with HFE mutation. Ped Pol. 2014;89(6):406-409.
- Kaczorowska-Hać B, Maciejka-Kapuścińska L, Miłosz-Bartoszewicz E, Adamkiewicz-Drożyńska E. Coexistence of beta-thalassemia trait and hemochromatosis in 5-year-old girl of polish origin. JPHO 2013;35(3):239-240.
- Kaczorowska-Hac B, Szalewska M, Niedzwiecki M, Adamkiewicz-Drozynska E, Milosz E. Iron overload in two children after allogenic hematopoietic SCT with concomitant HFE p.s65c gene mutation. Blood&Lymph 2014;4(1):117.